GSK-3β downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Xi ^a   Liu, Yuanling ^a   Zhu, Jin ^a   Lei, Shipeng ^b   Dong, Yuan ^a   Li, Lingyu ^a   Jiang, Beibei ^a   Tan, Li ^a   Wu, Jingxian ^a   Yu, Shanshan ^a   Zhao, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Jiangjin Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, RAT; INDOLE DERIVATIVE; LITHIUM CHLORIDE; MALEIMIDE DERIVATIVE; NFE2L2 PROTEIN, RAT; TRANSCRIPTION FACTOR NRF2;

ANIMAL; BRAIN ISCHEMIA; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MALE; METABOLISM; NERVE CELL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN ISCHEMIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GLYCOGEN SYNTHASE KINASE 3 BETA; INDOLES; LITHIUM CHLORIDE; MALE; MALEIMIDES; NEURONS; NF-E2-RELATED FACTOR 2; RATS; SIGNAL TRANSDUCTION;

EID: 84957831271     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20196     Document Type: Article

References (36)

1. Doyle, K. P. & Simon, R. P. Mechanisms of ischemic brain damage. Neuropharmacology. 55, 310-318 (2008).
2. Danilov, C. A. et al. Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia. 57, 645-656 (2009).
3. Gu, J. et al. Icariside II enhances Nrf2 nuclear translocation to upregulate phase II detoxifying enzyme expression coupled with the ERK, Akt and JNK signaling path-ways. Molecules. 16, 9234-9244 (2011).
4. Hwang, Y. P. & Jeong, H. G. Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells. Toxicol. Appl. Pharmacol. 242(1), 18-28 (2010).
5. Calkins, M. J. et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegener-ative disease. Antioxid. Redox. Signal. 11, 497-508 (2009).
6. Dinkova-Kostova, A. T. et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA. 99, 11908-11913 (2002).
7. Zhang, D. D. & Hannink, M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23, 8137-8151 (2003).
8. Kobayashi, M. & Yamamoto, M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme. Regul. 46, 113-140 (2006).
9. Patricia, R. et al. SCF/β-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell. Biol. 31(6), 1121-1133 (2011).
10. James, W. K. & Anil, K. J. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J. 25, 1076-1087 (2011).
11. Magdalena, J. et al. Role of glycogen synthase kinase-3β in cardioprotection. Circ Res. 104, 1240-1252 (2009).
12. Alexander J. V. & Peter, S. K. GSK-3 beta and Wnt signaling in neurogenesis and bipolar disorder. Frontiers in Molecular Neuroscience. 5, 1-13 (2012).
13. Jaiswal, A. K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 36, 1199-1207 (2004).
14. Itoh, K. et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86 (1999).
15. Dhakshinamoorthy, S. & Jaiswal, A. K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductase1 gene. Oncogene. 20(29), 3906-3917 (2001).
16. Abhinav, K. J. & Anil, K. J. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J. Biol. Chem. 282, 16502-16510 (2007).
17. Chowdhry, S., Zhang, Y. & McMahon, M. Nrf2 is controlled by two distinct b-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene. 32, 3765-3781 (2013).
18. Rojo, A. I. et al. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. Free Radic. Biol. Med. 52(2), 473-487 (2012).
19. Gross, E. R., Hsu, A. K. & Gross, G. J. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 94, 960-966 (2004).
20. Park, S. S., Zhao, H., Jang, Y., Mueller, R. A. & Xu, Z. N6-(3-iodobenzyl)-adenosine-5-N-Methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J. Pharmacol Exp Ther. 318, 124-131 (2006).
21. Park, S. S., Zhao, H., Mueller, R. A. & Xu, Z. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J. Mol. Cell. Cardiol. 40, 708-716 (2006).
22. Susan, A. et al. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radical Biology and Medicine. 67, 387-395 (2014).
23. Katja, K. et al. Targeting glycogen synthase kinase-3β for therapeutic benefit against oxidative stress in Alzheimer's Disease: involvement of the Nrf2-ARE pathway. In. J. Alzheimer's Disease. 2011, 985-085 (2011).
24. Zhou, Y., Xie, N., Li, L., Zou, Y., Zhang, X. & Dong, M. N. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. Int. J. Neuropsychopharmacol. 17(4), 635-44 (2014).
25. Suryakant, K. et al. Src subfamily kinases regulate nuclear factor Nrf2 to switch Off Nrf2-mediated export and degradation of transcription antioxidant activation of cytoprotective gene expression. J. Biol. Chem. 286(33), 28821-28832 (2011).
26. Ana, I. et al. GSK-3b down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. Neurochem. 105, 192-202 (2008).
27. Abhinav, K. J.& Anil, K. J. Phosphorylation of Tyrosine 568 Controls Nuclear Export of Nrf2. J. Biol. Chem. 281(17), 12132-12142 (2006).
28. 2+ signals by phosphatidylinositol-linked novel D1 dopamine receptor in hippocampal neurons. J. Neurochem. 98, 1316-1323 (2006).
29. Wu, X. et al. Sulforaphane protects primary cultures of cortical neurons against injury induced by oxygen-glucose deprivation/reoxygenation via antiapoptosis. Neurosci. Bull. 28, 509-516 (2012).
30. Tauskela, J., Brunette, E., Monette, R., Comas, T. & Morley, P. Preconditioning of cortical neurons by oxygen-glucose deprivation: tolerance induction through abbreviated neurotoxic signaling. Am. J. Physiol. Cell. Physiol. 285, C899-C911 (2003).
31. Xiang, J. et al. Apocynum venetum leaf extract protects rat cortical neurons from injury induced by oxygen and glucose deprivation in vitro. Can. J. Physiol. Pharmacol. 88, 907-917 (2010).
32. Xuefei, W. et al. Promotion of dentin regeneration via CCN3 modulation on Notch and BMP signaling pathways. Biomaterials. 35, 2720-2729 (2014).
33. Chen, Y. et al. Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. PloS. One. 7(6), e40165 (2012).
34. Yu, S. S., Zhao, J., Zheng, W. P. & Zhao, Y. Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via antiapoptosis in rats. Brain Res. 1308, 167-175 (2010).
35. Gross, E. R., Hsu, A. K. & Gross, G. J. Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP and MPTP-dependent mechanism at reperfusion. Am. J. Physiol. Heart. Circ. Physiol. 294, H1497-H1500 (2008).
36. Salazar, M. et al. Glycogen synthase kinase-3 inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J. Biol. Chem. 281, 14841-14851 (2006).